00003-2328
                        
                    
                            Yervoy
                        
                    
                                    Ipilimumab
                                
                            
                        
                    
                            Injection
                        
                    
                                    Intravenous
                                
                            
                        
                    
                                     Ipilimumab
                                
                                
                                     5.0
                                
                                
                                     mg/mL
                                
                                
                            
                        
                    
                                     00003-2328-22
                                
                                
                                     1 VIAL, SINGLE-USE in 1 CARTON (0003-2328-22)  / 40 mL in 1 VIAL, SINGLE-USE
                                
                                
                                     March 25, 2011
                                
                                
                                    Immunotherapy
                                
                            
                        
                    
                                    Checkpoint Inhibitor
                                
                            
                        
                    
                                    CTLA-4
                                
                            
                        
                    
                            In Use
                        
                     An official website of the United States government
 An official website of the United States government
		 Home
 Home 
                             
                    